Literature DB >> 4155969

Blockade of peripheral vascular responses to isoprenaline by three beta-adrenoceptor antagonists in the anaesthetized dog.

R Hainsworth, F Karim, J B Stoker.   

Abstract

1 A dog's hind limb was vascularly isolated by strong nylon snares and its sympathetic nerve supply interrupted. Blood was perfused at constant flow into the femoral artery and drained from the femoral vein. In some dogs the cardiac nerves were cut.2 Isoprenaline infused intravenously caused an increase in heart rate and a decrease in arterial resistance.3 Practolol (2 mg/kg) effectively blocked heart rate responses to isoprenaline infused at up to 10 mug/min but was relatively ineffective in blocking arterial responses. ICI 66082 (2 mg/kg) reduced vasomotor responses and propranolol (0.5 mg/kg) abolished vasomotor responses.4 Small cumulative doses of beta-adrenoceptor antagonists were given to some dogs. Practolol blocked heart rate responses in lower doses than were required to block vasomotor responses. Propranolol preferentially blocked vasomotor responses and ICI 66082 was intermediate between the other two in its effects.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4155969      PMCID: PMC1776741          DOI: 10.1111/j.1476-5381.1974.tb09643.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  The physiology of the veins.

Authors:  J F Donegan
Journal:  J Physiol       Date:  1921-08-03       Impact factor: 5.182

2.  The actions of selective beta-receptor antagonists on the guinea pig trachea.

Authors:  B Levy; B E Wilkenfeld
Journal:  Eur J Pharmacol       Date:  1970-07-01       Impact factor: 4.432

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Response of large hindlimb veins of the dog to sympathetic nerve stimulation.

Authors:  M M Webb-Peploe; J T Shepherd
Journal:  Am J Physiol       Date:  1968-08

5.  A system for the measurement of respiratory and acid-base parameters in blood.

Authors:  J Norman; J R Ledsome; R J Linden
Journal:  Br J Anaesth       Date:  1965-07       Impact factor: 9.166

6.  Studies on the nature of the bronchial -adrenoreceptors.

Authors:  J R Boissier; C Advenier; J F Giudicelli; P Viars
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

7.  A new type of cardioselective adrenoceptive blocking drug.

Authors:  A M Barrett; J Carter; J D Fitzgerald; R Hull; D Le Count
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

8.  Differentiation of receptors responsive to isoproterenol.

Authors:  A M Lands; F P Luduena; H J Buzzo
Journal:  Life Sci       Date:  1967-11-01       Impact factor: 5.037

9.  The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.

Authors:  J D Harry; M F Knapp; R J Linden
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

10.  Selective blockade of beta-adrenoceptors by 1-(p-allylphenoxy)-3-isopropylamino-2 propanol hydrochloride (h 64-52) in the anaesthetized dog.

Authors:  B Levy
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

View more
  10 in total

1.  The subdivision of beta-adrenoceptors in the cardiovascular system of the rat.

Authors:  F J Imms; R L Neame; D A Powis
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

2.  An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.

Authors:  G E Marlin; C R Kumana; C M Kaye; D M Smith; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

3.  The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

4.  Beta adrenoceptors in the hepatic arterial vascular bed of the dog [proceedings].

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

5.  Metabolic clearance rate of cortisol and aldosterone during controlled hyperthermia in man [proceedings].

Authors:  K J Collins; J D Few; J P Finberg
Journal:  J Physiol       Date:  1977-06       Impact factor: 5.182

Review 6.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

7.  Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.

Authors:  F J Conway; J D Fitzgerald; J McAinsh; D J Rowlands; W T Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

8.  The selectivity of beta-adrenoceptor antagonists on isoprenaline-induced changes in heart rate, blood pressure, soleus muscle contractility and airways function in anaesthetized cats.

Authors:  L G Letts; D P Richardson; D M Temple; L R Williams
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

9.  Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.

Authors:  J F De Plaen; A Amery; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

10.  Pharmacokinetics, pharmacology of atenolol and effect of renal disease.

Authors:  S H Wan; R T Koda; R F Maronde
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.